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ABSTRACT
Introduction: Low carbohydrate diets are again
in the spotlight and have been identified as
particularly appropriate for people with type 2
diabetes. There is confusion amongst both
health professionals and people with diabetes
about the suitability of these diets. This review
aims to provide an overview of the latest
evidence and to explore the role of low
carbohydrate diets for people with type 2
diabetes.
Methods: An electronic search of English
language articles was performed using
MEDLINE (2010–May 2015), EMBASE
(2010–May 2015), and the Cochrane Central
Register of Controlled Trials (2010–May 2015).
Only randomized controlled trials comparing
interventions evaluating reduced carbohydrate
intake with higher carbohydrate intake in
people with diagnosed type 2 diabetes were
included. Primary outcomes included weight,
glycated hemoglobin, and lipid concentrations.
Results: Low carbohydrate diets in people with
type 2 diabetes were effective for short-term
improvements in glycemic control, weight loss,
and cardiovascular risk, but this was not
sustained over the longer term. Overall, low
carbohydrate diets failed to show superiority
over higher carbohydrate intakes for any of the
measures evaluated including weight loss,
glycemic control, lipid concentrations, blood
pressure, and compliance with treatment.
Conclusion: Recent studies suggest that low
carbohydrate diets appear to be safe and
effective over the short term, but show no
statistical differences from control diets with
higher carbohydrate content and cannot be
recommended as the default treatment for
people with type 2 diabetes.
Keywords: Cardiovascular risk; Glycemic
control; Low carbohydrate diet; Type 2
diabetes; Weight loss
INTRODUCTION
Diabetes mellitus has long been considered a
disease of carbohydrate metabolism, and before
the discovery of insulin in 1921, low
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carbohydrate starvation diets were the default
treatment [1]. From the 1930s through to the
1960s, many experts continued to advise strict
carbohydrate restriction, with the result that
most people with diabetes adopted a high fat,
low carbohydrate diet [2]. However, some early
work in the 1920s and 1930s had suggested that
high carbohydrate diets improved glucose
tolerance, and the dramatic increase in deaths
from vascular disease in those whose lives were
prolonged by insulin treatment led to a
volte-face in the 1980s, with authorities now
recommending low fat, high carbohydrate diets
[3]. The pendulum has again swung the other
way, and there is renewed interest in very low
carbohydrate diets for the treatment of diabetes,
with various physicians extolling the virtues of
dietary carbohydrate restriction as the first
approach in diabetes management [4], and
some authorities recognizing low carbohydrate
diets as a suitable weight-loss strategy for those
with type 2 diabetes [5, 6].
Interestingly, the carbohydrate debate seems
to be based on strong personal opinion and
those working in the area tend to cherry-pick
the evidence to support their particular view,
whether that of low, moderate, or high
carbohydrate. Debates about the issue can
become very passionate, and it is worth
reminding ourselves that ‘‘passion in science is
an infallible marker of lack of evidence’’ [3]. The
evidence available is contradictory at best, and
leaves both health professionals and people
with diabetes alike wondering if low
carbohydrate diets do live up to the hype
surrounding them, and whether they should
be recommended as a suitable treatment.
Recent systematic reviews and meta-analyses
including people with type 2 diabetes report
that although low carbohydrate diets lead to
significantly greater weight loss and
improvements in glycated hemoglobin
(HbA1c) and lipids over the short term [7, 8],
there is no greater advantage over the longer
term [9, 10]. Despite this evidence, low
carbohydrate diets remain an area of
controversy and this review aims to provide an
overview of the latest evidence, and to explore
the role of low carbohydrate diets for people
with type 2 diabetes. This article is based on
previously conducted studies, and does not
involve any new studies of human or animal
subjects conducted by the author.
DEFINITION OF LOW
CARBOHYDRATE DIETS
One of the issues with the term ‘‘low
carbohydrate’’ is uncertainty about what this
means in terms of carbohydrate intake. Ketosis
readily occurs at carbohydrate intakes below
50 g/day [11], and these very low carbohydrate,
ketogenic diets (VLCKD) appear to have more
pronounced effects than other, less restricted
carbohydrate diets [12]. The taxonomy for diets
containing various amounts of dietary
carbohydrate has been suggested in a recent
paper [4], see Table 1. In practice, most
Atkins-style diets are designed to be very low
in carbohydrate (less than 20 g/day initially)
and high in protein and fat [13], and other
diets, e.g., the Zone [14] and the South Beach
Diet [15], promote a moderate carbohydrate
restriction together with high protein and low
fat intakes.
The Role of Low Carbohydrate Diets
in Treating Type 2 Diabetes
Treating type 2 diabetes is challenging,
encompassing as it does management of
glycemia, cardiovascular disease (CVD) risk
factors, obesity, and other co-morbidities by a
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combination of lifestyle strategies (diet and
physical activity), behavioral and
psychological interventions, pharmaceutical
treatment, and bariatric surgery. Medical
management of type 2 diabetes has led to
cynicism about the efficacy of lifestyle
management, particularly dietary strategies,
and at present the components of the most
effective diet remain unknown. A recent
systematic review and meta-analysis suggested
that low carbohydrate, low glycemic index (GI),
Mediterranean, and high protein diets all
showed greater improvements in glycemic
control than control diets [16]. Despite
criticism of the statistical analysis due to
heterogeneity of the studies included [17], this
review supports the premise that improvements
in glycemic control, CVD risk, and weight loss
are achievable with different diets with varying
amounts of carbohydrate, and that low
carbohydrate diets are not necessarily superior
in effect.
METHODS
This present review includes recent studies
published since 2010. An electronic search of
English language articles was performed using
MEDLINE (2010–May 2015), EMBASE
(2010–May 2015), and the Cochrane Central
Register of Controlled Trials (2010–May 2015)
using the search terms ‘‘low carbohydrate diet’’
and ‘‘type 2 diabetes’’. The selection criteria
included all randomized controlled trials
(RCTs) comparing interventions evaluating
reduced carbohydrate intake with higher
carbohydrate intake in people with diagnosed
type 2 diabetes. Primary outcomes included
weight, HbA1c, and lipid concentrations.
The title and abstract of each record retrieved
from the search were screened by the author
(PAD), and full articles were retrieved if the
information given suggested that the study met
the selection criteria. Data were extracted using
a specially designed form and included
information about authors, country, year of
publication, primary and secondary outcomes,
intervention, and outcomes.
RESULTS
From 253 search results, 21 articles were
retrieved for assessment of eligibility. Thirteen
of these studies were excluded and eight met
the inclusion criteria [18–25]. The flow diagram
illustrating the search and selection of studies is
shown in Fig. 1. A descriptive summary of the
included trials and main results are shown in
Tables 2, 3, and 4. It proved impossible to
combine the results of the eight selected
Table 1 Taxonomy of diets containing differing amounts of carbohydrate
Description Amount of carbohydrate
g/day % total energy intake
Very low carbohydrate ketogenic diet 20–50 B10
Low carbohydrate \130 \26
Moderate carbohydrate 130–230 26–45
High carbohydrate [230 [45
Adapted from Feinman et al. [4]
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studies using statistical methods as the studies
were heterogeneous in terms of the dietary
intervention (carbohydrate intakes ranged
from more than 20 g to 166 g/day), length of
follow-up (6–24 months), data quality, and data
reporting. For this reason a narrative review was
undertaken.
Weight Loss
All eight studies reported weight loss in the
group receiving the reduced carbohydrate
intervention, with mean weight losses ranging
from 1.7 kg [18] to 12.0 kg [25]. The greatest
weight loss was reported in the shortest study
lasting 6 months [25]. There appeared to be no
relationship between degree of carbohydrate
restriction and weight loss. However, these
studies all included a control group receiving
dietary interventions that provided higher
carbohydrate intakes but were designed for
weight loss, consequently those in the control
groups also lost weight during the course of the
studies. Mean weight losses in the control group
were similar to those in the reduced
carbohydrate group and ranged from 0.2 kg
[18] to 11.5 kg [25], with the result that none
of the eight studies reported significantly
greater weight loss in the group receiving the
reduced carbohydrate intervention.
Glycemic Control
Despite no significant differences in weight
losses, three of the studies reported
significantly greater reductions in HbA1c in
the reduced carbohydrate intervention group
[19, 23, 24]. One of the studies did not report
Fig. 1 Study ﬂow diagram showing number of studies screened, assessed for eligibility, and included in the narrative review
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T
ab
le
2
D
es
cr
ip
ti
ve
su
m
m
ar
y
of
re
ce
nt
lo
w
ca
rb
oh
yd
ra
te
tr
ia
ls
fo
r
pe
op
le
w
it
h
ty
pe
2
di
ab
et
es
Fi
rs
t
au
th
or
,
ye
ar
D
ur
at
io
n
(m
on
th
s)
N
um
be
rs
D
ie
t
I
C
I
C
Iq
ba
l,
20
10
[1
8]
24
70
74
B
30
g/
da
y
ca
rb
oh
yd
ra
te
B
30
%
fa
t,
50
0
kc
al
/d
ay
en
er
gy
de
ﬁc
it
E
lh
ay
an
y,
20
10
[1
9]
12
85
17
4
35
%
ca
rb
oh
yd
ra
te
,4
5%
fa
t
(5
0
%
of
w
hi
ch
w
as
M
U
FA
)
1.
A
D
A
di
et
:
50
–5
5%
ca
rb
oh
yd
ra
te
,1
5–
10
%
pr
ot
ei
n,
30
%
to
ta
l
fa
t
2.
M
ed
it
er
ra
ne
an
di
et
:
as
A
D
A
di
et
,b
ut
M
U
FA
fa
t
L
ar
se
n,
20
11
[2
0]
12
53
46
40
%
ca
rb
oh
yd
ra
te
,3
0%
pr
ot
ei
n,
30
%
fa
t
55
%
ca
rb
oh
yd
ra
te
,1
5%
pr
ot
ei
n,
30
%
fa
t
G
ul
db
ra
nd
,2
01
2
[2
1]
24
30
31
20
%
ca
rb
oh
yd
ra
te
,3
0%
pr
ot
ei
n,
50
%
fa
t
55
–6
0%
ca
rb
oh
yd
ra
te
,1
0–
25
%
pr
ot
ei
n,
30
%
fa
t
K
re
bs
,2
01
3
[2
2]
24
20
7
21
1
40
%
ca
rb
oh
yd
ra
te
,3
0%
pr
ot
ei
n,
30
%
fa
t
55
%
ca
rb
oh
yd
ra
te
,1
5%
pr
ot
ei
n,
30
%
fa
t
M
ay
er
,2
01
4
[2
3]
11
.5
22
24
B
20
g/
da
y
ca
rb
oh
yd
ra
te
B
30
%
fa
t,
50
0–
10
00
kc
al
/d
ay
en
er
gy
de
ﬁc
it
an
d
or
lis
ta
t
Y
am
ad
a,
20
14
[2
4]
6
12
12
70
–1
30
g/
da
y
ca
rb
oh
yd
ra
te
to
av
oi
d
ke
to
si
s
50
–6
0%
ca
rb
oh
yd
ra
te
,\
20
%
pr
ot
ei
n,
\
25
%
fa
t,
w
it
h
en
er
gy
re
st
ri
ct
io
n
ba
se
d
on
Ja
pa
ne
se
re
co
m
m
en
da
ti
on
s
T
ay
,2
01
5
[2
5]
6
46
47
\
50
g/
da
y
ca
rb
oh
yd
ra
te
(1
4%
)
53
%
lo
w
G
I
ca
rb
oh
yd
ra
te
,1
7%
pr
ot
ei
n,
30
%
fa
t
A
D
A
A
m
er
ic
an
D
ia
be
te
s
A
ss
oc
ia
ti
on
,C
co
m
pa
ra
to
r,
G
I
gl
yc
em
ic
in
de
x,
I
in
te
rv
en
ti
on
,M
U
FA
m
on
ou
ns
at
ur
at
ed
fa
tt
y
ac
id
s
Diabetes Ther (2015) 6:411–424 415
HbA1c [25] despite the fact that this
measurement was defined as the primary
outcome, leading to the speculation that there
were no differences in glycemic control
between the two groups [26]. This has now
been confirmed, with recent publication of a
follow-up at 12 months reporting no difference
in HbA1c reductions between the low and high
carbohydrate intakes [27]. Changes in HbA1c in
the reduced carbohydrate intervention groups
were variable between studies, ranging from
?0.1% [22] to -2.0% [19], with the greatest
reduction seen in studies of shorter duration.
There appeared to be little correlation between
the degree of carbohydrate restriction and
changes in glycemic control. HbA1c levels
were also reduced in five of the seven control
groups, with changes ranging from ?0.1% [22]
to -0.3% [20]. In summary, one study failed to
report HbA1c [25], three studies showed
significant reductions in HbA1c in the reduced
carbohydrate group [19, 23, 24], and four
studies showed no significant differences
between the two groups [18, 20–22].
Cardiovascular Risk
Cardiovascular risk was assessed by changes in
lipid concentrations and blood pressure. All
eight studies measured lipid concentrations,
and seven studies measured blood pressure
[18, 20–25]. Most studies reported reductions
in lipid concentrations in both the reduced
carbohydrate intervention and higher
carbohydrate control group, with no
significant differences between the two groups.
However, significantly greater reductions in the
reduced carbohydrate group were reported for
total cholesterol concentrations in one study
[22], low density lipoprotein (LDL) and high
density lipoprotein (HDL) concentrations in
one study [19], and triglycerides in three
studies [19, 22, 25]. Changes in blood pressure
were variable and showed no significant
differences in six of the seven studies reporting
outcomes; four studies reported reductions in
systolic blood pressure (SBP) in the reduced
carbohydrate group compared to the higher
carbohydrate group [18, 20, 23, 25], and three
Table 3 Summary of results of recent low carbohydrate trials for people with type 2 diabetes (body weight and glycemic
control)
First author, year Body weight loss (kg) Changes in HbA1c (%)
I C I2 C P value I C I2 C P value
Iqbal, 2010 [18] 1.7 0.2 1.2 0.29 -0.1 -0.2 -0.1 NS
Elhayany, 2010 [19] 8.9 7.6 1.4 0.557 -2.0 -1.6 -0.4 0.88
Larsen, 2011 [20] 2.23 2.17 0.07 0.9 -0.23 -0.28 0.04 0.76
Guldbrand, 2012 [21] 2.0 2.9 -0.9 0.33 0.0 0.2 -0.2 0.76
Krebs, 2013 [22] 3.9 6.0 -2.1 0.73 0.1 0.1 0.0 0.5
Mayer, 2014 [23] 7.5 8.1 -0.6 0.8 -0.7 0.2 -0.8 0.045
Yamada, 2014 [24] 2.6 1.4 1.2 0.8 -0.6 0.2 -0.4 0.03
Tay, 2014 [25] 12.0 11.5 0.5 0.57 NR NR NR NR
C comparator, HbA1c glycated hemoglobin, I intervention, NR not reported, NS no signiﬁcant difference
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reported increases [21, 22, 24]; for diastolic
blood pressure four reported decreases in the
reduced carbohydrate intervention group [18,
20, 23, 25] and three reported increases [21, 22,
24]. In summary, although there was no
evidence of a deleterious effect of a reduced
carbohydrate diet on CVD risk, equally, there
was no evidence of superiority over a higher
carbohydrate intake.
Adherence and Attrition
Adherence to the prescribed intervention was
assessed by self-reported dietary intake using a
variety of methods including 24-hourdiet histories
and 3-, 4-, and 7-day food diaries. In the majority of
the studies, mean intake of carbohydrate in the
reduced carbohydrate intervention group was
higher than that prescribed; in only two studies
did the participants achieve target intakes [24, 25].
Attrition rates were reported for seven studies, and
ranged from no dropouts [24] to 60 % [18]. There
were no differences in attrition rates between the
intervention and control groups in any of the
studies. In general, lower attrition rates were
reported for shorter studies, and for those with
fewer participants.
DISCUSSION
This review of recent studies evaluating the
effects of low carbohydrate diets in people with
Table 4 Summary of results of recent low carbohydrate trials for people with type 2 diabetes (cardiovascular risk)
First
author, year
Total
cholesterol
(mmol/L)
HDL
(mmol/L)
LDL
(mmol/L)
Triglycerides
(mmol/L)
Systolic BP
(mm/Hg)
Diastolic BP
(mm/Hg)
I 2 C P value I 2 C P value I 2 C P value I 2 C P value I 2 C P value I2 C P value
Iqbal, 2010
[18]
0.03 NS 0.0 NS -0.06 NS -0.14 NS -6.7 NS 0.5 NS
Elhayany,
2010 [19]
-0.02 0.204 0.18 \0.001 -0.24 0.036 -0.64 \0.001 NR NR NR NR
Larsen, 2011
[20]
-0.16 0.32 0.01 0.84 -0.01 0.3 -0.17 0.34 -4.3 0.05 -0.4 0.7
Guldbrand,
2012 [21]
0.2 0.33 0.12 0.15 0.0 0.16 0.1 0.35 2 0.74 3 0.75
Krebs, 2013
[22]
-0.07 0.03 0.01 0.41 0.03 0.32 -0.03 0.02 1 0.87 0.0 0.96
Mayer, 2014
[23]
0.23 0.4 0.03 0.5 0.25 0.3 -0.28 0.3 -11 0.006 -6 0.013
Yamada,
2014 [24]
NR NR 0.25 0.13 -0.08 0.49 -0.58 0.08 1.7 0.54 -4.6 0.3
Tay, 2014
[25]
0.0 0.89 NR NR 0.0 0.81 -0.4 0.001 -2.3 0.26 -1.8 0.1
BP blood pressure, C comparator, HDL high density lipoprotein, I intervention, LDL low density lipoprotein, NR not
reported, NS no signiﬁcant difference
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type 2 diabetes supports previous meta-analyses
showing that although there may be greater
short-term improvements in glycemic control,
weight loss, and CVD risk, this is not sustained
over the longer-term. Many studies have
attempted to determine the ideal
macronutrient (protein, fat, and carbohydrate)
intake for people with type 2 diabetes, and
evidence to date is inconclusive [28]. One of
the best predictors of improved outcomes in
people with type 2 diabetes is energy restriction
and weight loss, and there are a variety of
strategies by which this may be achieved, with
no clear indication of the superiority of low
carbohydrate diets. This is true for both those
with type 2 diabetes [28] and those without [10,
29, 30]. Much of the positive effect of low
carbohydrate diets is due to weight loss, and the
effect independent of weight change is difficult
to assess.
In the absence of categorical evidence
supporting the use of low carbohydrate diets,
one wonders why they have gained such strong
support and media attention over the past few
years. Many proponents of low carbohydrate
diets maintain that recent healthy eating
guidelines promoting carbohydrate and
restricting fat have been counterproductive
and have led to escalating rates of obesity and
type 2 diabetes [31]. The cause of obesity is
extremely complex [32] and it is unlikely that
one factor, that of carbohydrate intake, is the
root cause. There is also contrary evidence
indicating that diets high in fruit, vegetables,
whole grains, and legumes (all of which contain
carbohydrate) actually protect against obesity,
CVD, and, to a lesser extent, type 2 diabetes
[33]. Studies often fail to address the type of
carbohydrate included in the diet, and this may
affect outcomes [34]. There is now
accumulating evidence that unprocessed
carbohydrates, including whole grains, fruit,
vegetables, and legumes, have health benefits
[35], and those from refined sources, including
white bread and white rice and particularly
sugar and sugar-sweetened beverages (SSB), are
associated with increased risk of obesity, CVD,
and type 2 diabetes [36–39]. It could be
speculated that the benefits of low
carbohydrate diets are associated with a
reduction in refined carbohydrate and not
total carbohydrate per se. For people with
type 2 diabetes, there is evidence from a large,
long-term RCT suggesting that higher
carbohydrate diets can improve weight loss,
glycemic control, and CVD risk factors
(although not CVD mortality) [40]. The Look
AHEAD trial (ClinicalTrials.gov identifier,
NCT0017953) reported greater weight loss,
improvements in glycemia and CVD risk
factors, and reduced risk of microvascular
complications, depression, sleep apnea, and
urinary incontinence at 9.6-year follow-up in
those allocated an intensive lifestyle education
(ILE) program compared to standard diabetes
education (DES) [41]. Those in the ILE group
were encouraged to increase physical activity
and adopt an energy-reduced, low fat, partial
meal replacement plan. At 1-year follow-up,
they derived a higher proportion of energy from
carbohydrate (ILE 50.8% vs. DES 42.5%) and a
lower proportion from fat (ILE 34.2% vs. DES
39.7%), demonstrating that a higher
carbohydrate, lower fat diet was associated
with improved outcomes [42].
Disadvantages of Low Carbohydrate Diets
Concern has been expressed about the
long-term health effects of low carbohydrate
diets on renal function, calcium metabolism,
lack of essential nutrients, and CVD risk [43],
and a systematic review and meta-analysis
reported that low carbohydrate diets were
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associated with a significantly higher risk of
all-cause mortality [44]. Reductions in
carbohydrate intake may also be associated
with an increased risk of hypoglycemia in
those treated with insulin or insulin
secretagogues, and to reduce this medical
supervision, reductions in medication and
self-monitoring of blood glucose
concentrations are recommended for those
adopting a low carbohydrate diet.
Low carbohydrate diets tend to be higher in
protein, and this may have an adverse effect on
renal function [45]. There are very few studies
investigating renal function and low
carbohydrate diets, although a recent study
suggested that improvements in renal function
are related to weight loss, and that this occurs to
a similar extent with low carbohydrate,
Mediterranean, and low fat diets [46]. In obese
people without diabetes, studies have shown
that low carbohydrate diets have no harmful
effects on glomerular filtration rate (GFR),
albuminuria, fluid or electrolyte balance when
compared to a low fat diet [47, 48].
It has been postulated that as very low
carbohydrate diets cause ketosis, this induces
acidosis, promoting urinary calcium loss and
leading to low bone mineral density and
increased risk of osteoporosis. There is very
little research in this field, and none at all in
people with diabetes, making it challenging to
draw firm conclusions. One animal study
showed that low carbohydrate diets induce
low bone mineral density in rats [49], and two
small studies in obese subjects reported
deleterious effects on urinary calcium loss [47]
and markers for bone formation [50].
Conversely, another study reported no effect
of a low carbohydrate diet on bone turnover
markers [51]. The long-term effects of low
carbohydrate diets on calcium metabolism and
bone health are unknown.
Other claims about the negative aspects of
low carbohydrate diets include that of
nutritional deficiencies, namely those
commonly found in unprocessed carbohydrate
foods including vitamins, minerals, dietary
fiber, and phytochemicals with antioxidant
properties [52]. There is no evidence to either
endorse or refute this suggestion, although a
computer-generated analysis showed that low
carbohydrate diets are deficient in many
micronutrients [53], and an analysis of four
popular diets from the USA (Atkins, LEARN,
Ornish, and Zone) demonstrated that all diets
showed a degree of deficiency: specifically
thiamine, folic acid, vitamin C, iron, and
magnesium in the case of low carbohydrate
diets [54]. Low carbohydrate diets may be low in
dietary fiber and epidemiological evidence
suggests that low intakes of dietary fiber are
associated with increased risk of lower
gastrointestinal disorders, including colon
cancer [34, 55], and this may be further
exacerbated by high intakes of red meat and
meat products [56].
The most controversial aspect of low
carbohydrate diets is that they may increase
the risk of CVD as they are associated with
higher total and saturated fat intakes. There is
little evidence for this in people with type 2
diabetes as there are very few studies; as a result
many commentators have extrapolated from
studies in the general population. There are
some issues with the quality of evidence used to
define the relationship between fat intake and
CVD risk as most studies are short-term RCTs
with surrogate end points, or observational and
epidemiological studies, where associations do
not prove causation. Recent meta-analyses and
systematic reviews have reported that there is
no association between CVD and type of dietary
fat, whether saturated fatty acids (SFA),
polyunsaturated fatty acids (PUFA), or
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monounsaturated fatty acids (MUFA) [57, 58],
leading to headlines stating that scientists have
been wrong for decades and have mislead the
public with low-fat, healthy eating
recommendations. However, both these
reviews have been widely criticized for
omitting important cohort studies, incorrect
extraction of data, incorrect interpretation, and
a failure to mention the results of other,
superior analyses [59]. Many experts still
maintain that there is an association between
SFA and CVD [60], and that the evidence
supports substitution of SFA by unsaturated fat
[61]. The recently published Cochrane review
also supports this recommendation, stating that
there is a small but potentially important
reduction in CVD risk with the reduction of
SFA [62]. It is worth remembering that most
studies examining the relationship between fat
intake and CVD include fat intakes in a fairly
narrow range of approximately 30–40 % of total
energy intake, and little is known about the
relative effects of intakes above these values.
This may be an issue for some individuals
adopting a low carbohydrate diet where fat,
often SFA, is actively promoted to induce
ketosis and increase palatability. As is the case
with glycemic control, weight reduction
improves CVD risk factors and if weight loss is
achieved, there are no significant differences
between either low fat, high carbohydrate diets
and low carbohydrate diets for primary
prevention of CVD [63]. On balance, there is
little evidence to support changing current
recommendations for fat intake in people with
type 2 diabetes.
There is a further consideration that is now
coming to the fore, and that is the challenge of
sustainable nutrition. Sustainable diets, as
defined by the Food and Agriculture
Organization (FAO), are nutritionally
adequate, safe, affordable, and culturally
acceptable and are sparing of natural and
human resources [64]. The carbon footprint of
different foodstuffs has been investigated, and
the results show that red meat is the most
carbon intensive process, followed by dairy,
fruit, chicken, and vegetables. Cereals, oils, and
sugar are the least carbon intensive [65]. Low
carbohydrate diets tend to include foods with
the biggest carbon footprint and large-scale
adoption of these diets will increase
greenhouse gas emissions. In terms of cultural
acceptance, proponents of low carbohydrate
diets for diabetes could be accused of elitism.
Newly industrialized countries such as China
and India are experiencing a rapid increase in
the prevalence of diabetes [66, 67], and it is
estimated that by 2030, 551 billion people
(10 % of the world’s population) will have
diabetes [68]. For many of these people, a low
carbohydrate diet is either unacceptable for
religious or cultural reasons, or simply
unaffordable.
CONCLUSIONS
To date the evidence suggests that low
carbohydrate diets are effective for weight loss
and improvements in glycemic control and
CVD risk, but that they are not superior to
other dietary approaches. For this reason, low
carbohydrate diets cannot be recommended as
the default strategy for people with type 2
diabetes. However, they are another useful
tool for those who wish to adopt them,
although long-term side effects of these diets
remain unknown.
The question remains—how much
carbohydrate should someone with type 2
diabetes eat? Both Diabetes UK and the
American Diabetes Association recommend an
individualized approach, where health
420 Diabetes Ther (2015) 6:411–424
professionals work with the person with
diabetes to identify an eating pattern that is
based on that individual’s lifestyle, culture, and
preferences. Both authorities identify
carbohydrate management as a key strategy
and address both type and amount of
carbohydrate, emphasizing unprocessed
carbohydrate from whole grains, fruit, and
vegetable sources.
Perhaps it is time to abandon the
macronutrient approach to nutritional advice
and begin to talk about specific foods and eating
patterns and encourage those associated with
health. There is no ‘‘ideal’’ eating pattern that
will benefit all people with diabetes, although
total energy intake is an important
consideration, especially in those who are
overweight or obese. Epidemiological and
observational studies show that there are
dietary patterns that are associated with better
overall health outcomes and which are rich in
vegetables, fruit, whole grains, seafood,
legumes, and nuts, contain moderate amounts
of dairy products, and are lower in red and
processed meat, sugar, and refined grains. In
summary, although low carbohydrate diets
appear to be safe and effective in people with
diabetes, there are more sustainable alternatives
available and this should be fully explained to
all those with type 2 diabetes.
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